Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vik Meadows

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
AME Medical Journal|December 4, 2018
MicroRNAs and cholangiocarcinoma: elucidating the effects of tiny giantsVik Meadows, Heather Francis
Cellular and Molecular Gastroenterology and Hepatology|December 5, 2023
New Kids on the Block: Immature Myeloid Cells in Intestinal RegenerationVik Meadows, Nan Gao
Hepatology (Baltimore, Md.)|November 12, 2020
Doublecortin-Like Kinase Protein 1 in Cholangiocarcinoma: Is This the Biomarker and Target We Have Been Looking For?Vik Meadows, Heather Francis
Hepatology Communications|April 14, 2023
FXR and NASH: an avenue for tissue-specific regulationZakiyah Henry, Vik Meadows, Grace L Guo
Seminars in Liver Disease|July 13, 2023
FXR Friend-ChIPs in the Enterohepatic SystemVik Meadows, Zhenning Yang, Veronia Basaly, et al.
The FEBS Journal|November 26, 2024
Ruminococcus gnavus in the gut: driver, contributor, or innocent bystander in steatotic liver disease?Vik Meadows, Jayson M Antonio, Ronaldo P Ferraris, et al.
Frontiers in Medicine|February 18, 2020
Bile Acid Receptor Therapeutics Effects on Chronic Liver DiseasesVik Meadows, Lindsey Kennedy, Debjyoti Kundu, et al.
FEBS Letters|October 15, 2024
The publish or perish game: an interview with the inventorDaisy Y Shu, Vik Meadows, Roberto Mota Alvidrez, et al.
Annual Review of Pathology|October 13, 2025
Zonation, Zonation, Zonation: The Real Estate of the LiverTyler M Yasaka, Chang Kyung Kim, Vik Meadows, et al.
Gene Expression|July 31, 2020
The Dynamic Interplay Between Mast Cells, Aging/Cellular Senescence, and Liver DiseaseDebjyoti Kundu, Lindsey Kennedy, Vik Meadows, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
AME Medical Journal|December 4, 2018
MicroRNAs and cholangiocarcinoma: elucidating the effects of tiny giantsVik Meadows, Heather Francis
Cellular and Molecular Gastroenterology and Hepatology|December 5, 2023
New Kids on the Block: Immature Myeloid Cells in Intestinal RegenerationVik Meadows, Nan Gao
Hepatology (Baltimore, Md.)|November 12, 2020
Doublecortin-Like Kinase Protein 1 in Cholangiocarcinoma: Is This the Biomarker and Target We Have Been Looking For?Vik Meadows, Heather Francis
Hepatology Communications|April 14, 2023
FXR and NASH: an avenue for tissue-specific regulationZakiyah Henry, Vik Meadows, Grace L Guo
Seminars in Liver Disease|July 13, 2023
FXR Friend-ChIPs in the Enterohepatic SystemVik Meadows, Zhenning Yang, Veronia Basaly, et al.
The FEBS Journal|November 26, 2024
Ruminococcus gnavus in the gut: driver, contributor, or innocent bystander in steatotic liver disease?Vik Meadows, Jayson M Antonio, Ronaldo P Ferraris, et al.
Frontiers in Medicine|February 18, 2020
Bile Acid Receptor Therapeutics Effects on Chronic Liver DiseasesVik Meadows, Lindsey Kennedy, Debjyoti Kundu, et al.
FEBS Letters|October 15, 2024
The publish or perish game: an interview with the inventorDaisy Y Shu, Vik Meadows, Roberto Mota Alvidrez, et al.
Annual Review of Pathology|October 13, 2025
Zonation, Zonation, Zonation: The Real Estate of the LiverTyler M Yasaka, Chang Kyung Kim, Vik Meadows, et al.
Gene Expression|July 31, 2020
The Dynamic Interplay Between Mast Cells, Aging/Cellular Senescence, and Liver DiseaseDebjyoti Kundu, Lindsey Kennedy, Vik Meadows, et al.
Pageof 5